Pulse Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +257.5% | +5.9% | +31.9% | +30.9% | -11.5% | -5.6% | +4.7% | +18.2% | -10.9% | -2.4% | -9.1% | |
| – | – | +116.4% | +1,155.9% | +12.9% | -8.5% | -10.7% | +44.9% | -64.4% | +38.3% | +89.2% | +57.9% | |
| – | – | – | +1,395.5% | -5.4% | -8.7% | -9.7% | +43.4% | – | – | – | – | |
| – | -1,453.8% | – | – | -72.3% | +661.1% | +272.1% | -293.7% | – | – | +221.9% | -303.2% | |
| – | +9.1% | -25.6% | +3,885.9% | -89.2% | +120.3% | -27.5% | -0.9% | -8.2% | -69.8% | +3.3% | +152.0% | |
| – | +11.5% | +16,616.3% | +59.9% | – | -138.7% | – | -24.7% | -105.3% | -69.8% | +3.3% | +168.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +52.4% | +0.0% | +69.2% | -100.3% | +433.0% | – | +65.3% | -40.0% | -18.7% | +21.0% | +22.6% | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +15,870.5% | -100.0% | – | – | |
| – | +70.5% | +0.0% | +69.2% | +28.6% | -99.8% | +37,564.6% | +103.0% | +27.5% | -79.5% | +572.1% | -84.4% | |
| – | -128.3% | – | – | +3,579.0% | -192.6% | – | +190.3% | +101.4% | -151.6% | – | -150.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.